Literature DB >> 22362139

Effect of polysorbate 80 quality on photostability of a monoclonal antibody.

Swita R Singh1, Jingming Zhang, Courtney O'Dell, Ming-Ching Hsieh, Joel Goldstein, Joseph Liu, Arvind Srivastava.   

Abstract

Polysorbate 80 is one of the key components of protein formulations. It primarily inhibits interfacial damage of the protein molecule due to mechanical stress during shipping and handling. However, polysorbate 80 also affects the formulation photostability. Exposure to light of polysorbate 80 aqueous solution results in peroxide generation, which in turn may result in oxidation of the susceptible amino acid residues in the protein molecule. The purpose of this study was to determine if the photostability of our proprietary IgG(1) monoclonal antibody formulation containing polysorbate 80 is affected by the quality (grade/vendor) of polysorbate 80. Following four types of polysorbate 80 were tested: (1) Polysorbate 80 Super-Refined, Mallinckrodt Baker, (2) Polysorbate 80 NF, Mallinckrodt Baker, (3) Polysorbate 80 NF, EMD Chemicals, and (4) Ultra-pure Polysorbate 80 (HX), NOF Corporation. The samples were exposed to light as per ICH guidelines Q1B. The results of the study show that photostability of the antibody formulation is indeed affected by the quality of polysorbate 80. This study underscores the importance of carefully choosing the quality of polysorbate 80 to ensure the robustness of formulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362139      PMCID: PMC3364395          DOI: 10.1208/s12249-012-9759-6

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  28 in total

Review 1.  Photo-oxidation of proteins and its role in cataractogenesis.

Authors:  M J Davies; R J Truscott
Journal:  J Photochem Photobiol B       Date:  2001-10       Impact factor: 6.252

2.  Determination of protein oxidation by mass spectrometry and method transfer to quality control.

Authors:  Damian Houde; Paivi Kauppinen; Rohin Mhatre; Yelena Lyubarskaya
Journal:  J Chromatogr A       Date:  2006-05-22       Impact factor: 4.759

3.  Shaken, not stirred: mechanical stress testing of an IgG1 antibody.

Authors:  Sylvia Kiese; Astrid Papppenberger; Wolfgang Friess; Hanns-Christian Mahler
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

Review 4.  Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods.

Authors:  J Vlasak; R Ionescu
Journal:  Curr Pharm Biotechnol       Date:  2008-12       Impact factor: 2.837

5.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants.

Authors:  B S Chang; B S Kendrick; J F Carpenter
Journal:  J Pharm Sci       Date:  1996-12       Impact factor: 3.534

6.  A stability study of chloramphenicol in topical formulations.

Authors:  K C James; R H Leach
Journal:  J Pharm Pharmacol       Date:  1970-08       Impact factor: 3.765

7.  The role of the methionine residues in the structure and function of parathyroid hormone.

Authors:  A L Frelinger; J E Zull
Journal:  Arch Biochem Biophys       Date:  1986-02-01       Impact factor: 4.013

8.  Quantitation of hydroperoxides in the aqueous solutions of non-ionic surfactants using polysorbate 80 as the model surfactant.

Authors:  S Ding
Journal:  J Pharm Biomed Anal       Date:  1993-02       Impact factor: 3.935

9.  Oxidation of recombinant human parathyroid hormone: effect of oxidized position on the biological activity.

Authors:  Y Nabuchi; E Fujiwara; K Ueno; H Kuboniwa; Y Asoh; H Ushio
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

10.  Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities.

Authors:  L C Teh; L J Murphy; N L Huq; A S Surus; H G Friesen; L Lazarus; G E Chapman
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

View more
  7 in total

Review 1.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

Review 2.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

Review 3.  Forced degradation of recombinant monoclonal antibodies: A practical guide.

Authors:  Christine Nowak; Jason K Cheung; Shara M Dellatore; Amit Katiyar; Ram Bhat; Joanne Sun; Gomathinayagam Ponniah; Alyssa Neill; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2017-08-30       Impact factor: 5.857

4.  Effect of polysorbate 80 concentration on thermal and photostability of a monoclonal antibody.

Authors:  Meera Agarkhed; Courtney O'Dell; Ming-Ching Hsieh; Jingming Zhang; Joel Goldstein; Arvind Srivastava
Journal:  AAPS PharmSciTech       Date:  2012-11-14       Impact factor: 3.246

5.  Effect of Nonionic Surfactants (Dodecyl Maltoside and Polysorbate 20) on Prevention of Aggregation and Conformational Changes of Recombinant Human IFNβ_1b Induced by Light.

Authors:  Najmeh Mahjoubi; Ahmad Fazeli; Rassoul Dinarvand; Mohammad Reza Khoshayand; Maryam Shekarchi; Mohammad Reza Fazeli
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

6.  Protein Formulations Containing Polysorbates: Are Metal Chelators Needed at All?

Authors:  Ema Valentina Brovč; Stane Pajk; Roman Šink; Janez Mravljak
Journal:  Antioxidants (Basel)       Date:  2020-05-20

Review 7.  Photo-Oxidation of Therapeutic Protein Formulations: From Radical Formation to Analytical Techniques.

Authors:  Elena Hipper; Michaela Blech; Dariush Hinderberger; Patrick Garidel; Wolfgang Kaiser
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.